Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Home-Use Device Categorization Based On Complexity Proposed By CDRH

This article was originally published in The Gray Sheet

Executive Summary

Manufacturer certification requirements may eventually accompany the regulation of certain home-use medical devices, Center for Devices & Radiological Health officials suggested Sept. 12

You may also be interested in...



FDA Weighing Alternative Pathways To Home Use Of Medical Devices

Third-party certification to permit device marketing for home use, in lieu of an additional 510(k) clearance, is one proposal under consideration by FDA's device center as it weighs how best to cope with the trend toward increased use of complex products in the home

FDA Weighing Alternative Pathways To Home Use Of Medical Devices

Third-party certification to permit device marketing for home use, in lieu of an additional 510(k) clearance, is one proposal under consideration by FDA's device center as it weighs how best to cope with the trend toward increased use of complex products in the home

Baxter Renal Services Divestment May Strengthen Home Health Care Business

Baxter International aims to expand its peritoneal and hemodialysis product offerings, particularly in the home setting, following a planned divestiture of the majority of its renal dialysis services

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017147

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel